XML 26 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Operating Activities:    
Net income $ 54,956 $ 62,137
Non-cash items included in net income:    
Depreciation and amortization 45,823 43,084
Provision for deferred income taxes (5,049) 17,614
Power and natural gas cost amortizations (deferrals), net 72 3,091
Amortization of debt expense 815 813
Amortization of investment in exchange power 613 613
Stock-based compensation expense 1,963 832
Equity-related AFUDC (1,392) (1,650)
Pension and other postretirement benefit expense 8,170 9,348
Other regulatory assets and liabilities and deferred debits and credits 2,127 (6,878)
Change in decoupling regulatory deferral 5,703 14,857
Other 3,778 (116)
Contributions to defined benefit pension plan (7,300) (7,400)
Changes in certain current assets and liabilities:    
Accounts and notes receivable 15,963 (668)
Materials and supplies, fuel stock and natural gas stored 8,815 6,129
Collateral posted for derivative instruments 18,382 (2,620)
Income taxes receivable 314 14,106
Other current assets (787) (116)
Accounts payable (21,997) (20,239)
Income taxes payable 15,432 0
Other current liabilities 38,374 16,778
Net cash provided by operating activities 184,775 149,715
Investing Activities:    
Utility property capital expenditures (excluding equity-related AFUDC) (81,817) (86,763)
Issuance of notes receivable at subsidiaries (1,000) (400)
Equity and property investments made by subsidiaries (3,671) (2,627)
Other (866) (137)
Net cash used in investing activities (87,354) (89,927)
Financing Activities:    
Net decrease in short-term borrowings (55,398) (15,000)
Maturity of long-term debt and capital leases (3,037) (822)
Issuance of common stock 232 315
Cash dividends paid (24,634) (23,167)
Other (4,483) (3,442)
Net cash used in financing activities (87,320) (42,116)
Net increase in cash and cash equivalents 10,101 17,672
Cash and cash equivalents at beginning of period 16,172 8,507
Cash and cash equivalents at end of period $ 26,273 $ 26,179